Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

Methods: We conducted a retrospective chart review of patients with COVID-19 diagnosed between March 1, 2020, and July 31, 2020, at any of the Mayo Clinic sites. We abstracted pertinent comorbid conditions such as age, sex, body mass index, Charlson Comorbidity Index variables, and treatments received. Factors associated with hospitalization and mortality were assessed in univariate and multivariate models.

Results: A total of 7891 patients with confirmed COVID-19 infection with research authorization on file received care across the Mayo Clinic sites during the study period. Of these, 7217 patients were adults 18 years or older who were analyzed further. A total of 897 (11.4%) patients required hospitalization, and 354 (4.9%) received care in the intensive care unit (ICU). All hospitalized patients were reviewed by a COVID-19 Treatment Review Panel, and 77.5% (695 of 897) of inpatients received a COVID-19-directed therapy. Overall mortality was 1.2% (94 of 7891), with 7.1% (64 of 897) mortality in hospitalized patients and 11.3% (40 of 354) in patients requiring ICU care.

Conclusion: Mayo Clinic outcomes of patients with COVID-19 infection in the ICU, hospital, and community compare favorably with those reported nationally. This likely reflects the impact of interprofessional multidisciplinary team evaluation, effective leveraging of clinical trials and available treatments, deployment of remote monitoring tools, and maintenance of adequate operating capacity to not require surge adjustments. These best practices can help guide other health care systems with the continuing response to the COVID-19 pandemic.

Citing Articles

The Mayo Brothers: Pioneers of Modern Medicine and Patient-Centered Care.

Gnanapandithan K, Pagan R, Cowart J Cureus. 2024; 16(10):e71269.

PMID: 39525208 PMC: 11550878. DOI: 10.7759/cureus.71269.

Remote Patient Monitoring at Home in Patients With COVID-19: Narrative Review.

Cornelis J, Christiaens W, de Meester C, Mistiaen P JMIR Nurs. 2024; 7:e44580.

PMID: 39287362 PMC: 11615560. DOI: 10.2196/44580.

Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records.

Bell C, Gibbons D, Drysdale M, Birch H, Lloyd E, Patel V PLoS One. 2024; 19(7):e0304822.

PMID: 39012863 PMC: 11251586. DOI: 10.1371/journal.pone.0304822.

Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis.

Sullivan M, Lei X, Giordano S, Chavez-MacGregor M Breast Cancer Res Treat. 2024; 206(2):307-316.

PMID: 38580882 PMC: 11813646. DOI: 10.1007/s10549-024-07301-1.

COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients.

Kasten M, Lahr B, Parisapogu A, Yetmar Z, OHoro J, Orenstein R Sci Rep. 2023; 13(1):21249.

PMID: 38040756 PMC: 10692159. DOI: 10.1038/s41598-023-48145-x.

References

Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K . SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020; 65(12):1075-1082. PMC: 7375454. DOI: 10.1038/s10038-020-0808-9. View

The Lancet Respiratory Medicine . The EVALI outbreak and vaping in the COVID-19 era. Lancet Respir Med. 2020; 8(9):831. PMC: 7428296. DOI: 10.1016/S2213-2600(20)30360-X. View

Shah A, Tande A, Challener D, OHoro J, Binnicker M, Berbari E . Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic. Mayo Clin Proc. 2020; 95(9S):S17-S19. PMC: 7309714. DOI: 10.1016/j.mayocp.2020.05.039. View

Ji W, Huh K, Kang M, Hong J, Bae G, Lee R . Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study. J Korean Med Sci. 2020; 35(25):e237. PMC: 7324262. DOI: 10.3346/jkms.2020.35.e237. View

Deyo R, Cherkin D, Ciol M . Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45(6):613-9. DOI: 10.1016/0895-4356(92)90133-8. View

Beigel J, Tomashek K, Dodd L . Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply. N Engl J Med. 2020; 383(10):994. DOI: 10.1056/NEJMc2022236. View

Marra A, Wesley Ely E, Pandharipande P, Patel M . The ABCDEF Bundle in Critical Care. Crit Care Clin. 2017; 33(2):225-243. PMC: 5351776. DOI: 10.1016/j.ccc.2016.12.005. View

Jones A, Trzeciak S, Kline J . The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009; 37(5):1649-54. PMC: 2703722. DOI: 10.1097/CCM.0b013e31819def97. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

10.

Shah A, Challener D, Tande A, Mahmood M, OHoro J, Berbari E . Drive-Through Testing: A Unique, Efficient Method of Collecting Large Volume of Specimens During the SARS-CoV-2 (COVID-19) Pandemic. Mayo Clin Proc. 2020; 95(7):1420-1425. PMC: 7252102. DOI: 10.1016/j.mayocp.2020.04.030. View

11.

Cheung J, Ho L, Cheng J, Cham E, Lam K . Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. 2020; 8(4):e19. PMC: 7128208. DOI: 10.1016/S2213-2600(20)30084-9. View

12.

Petrilli C, Jones S, Yang J, Rajagopalan H, ODonnell L, Chernyak Y . Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020; 369:m1966. PMC: 7243801. DOI: 10.1136/bmj.m1966. View

13.

Crane S, Ganesh R, Post J, Jacobson N . Telemedicine Consultations and Follow-up of Patients With COVID-19. Mayo Clin Proc. 2020; 95(9S):S33-S34. PMC: 7383136. DOI: 10.1016/j.mayocp.2020.06.051. View

14.

Levin A, Hanage W, Owusu-Boaitey N, Cochran K, Walsh S, Meyerowitz-Katz G . Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020; 35(12):1123-1138. PMC: 7721859. DOI: 10.1007/s10654-020-00698-1. View

15.

Yehia B, Winegar A, Fogel R, Fakih M, Ottenbacher A, Jesser C . Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals. JAMA Netw Open. 2020; 3(8):e2018039. PMC: 7435340. DOI: 10.1001/jamanetworkopen.2020.18039. View

16.

Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Adalia R . Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study. Crit Care. 2020; 24(1):597. PMC: 7537953. DOI: 10.1186/s13054-020-03314-6. View

17.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

18.

McBane 2nd R, Roldan V, Niven A, Pruthi R, Moreno Franco P, Linderbaum J . Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic. Mayo Clin Proc. 2020; 95(11):2467-2486. PMC: 7458092. DOI: 10.1016/j.mayocp.2020.08.030. View

19.

Lu Y, Chen P, Sheu C, Liu C . Viral load and outcome in SARS infection: the role of personal protective equipment in the emergency department. J Emerg Med. 2006; 30(1):7-15. PMC: 7126311. DOI: 10.1016/j.jemermed.2005.03.011. View

20.

Du Y, Lv Y, Zha W, Zhou N, Hong X . Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis. Metabolism. 2020; 117:154373. PMC: 7493748. DOI: 10.1016/j.metabol.2020.154373. View